Yudao Shen

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Methylation of dual-specificity phosphatase 4 controls cell differentiation”.

Methylation of dual-specificity phosphatase 4 controls cell differentiation

Cell Reports(2021)10.1016/j.celrep.2021.109421

N/A

1.1DataRank · unranked

34 citations

Ming Jiang, Chamara Senevirathne, Srinivas Aluri, Tuo Zhang, Han Guo +27 more

Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists

Figshare(2020)10.17615/6kd3-3g60

N/A

0DataRank · unranked

2 citations

Jian Jin, John D. McCorvy, Kyle V. Butler, Yudao Shen, Bryan L. Roth +2 more

A First-in-class, Highly Selective and Cell-active Allosteric Inhibitor of Protein Arginine Methyltransferase 6 (PRMT6)

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.04.412569

N/A

0DataRank · unranked

1 citations

Fengling Li, Magdalena M. Szewczyk, Levon Halebelian, Irene Chau, Mohammad S. Eram +19 more

Pharmacologic modulation of RNA splicing enhances anti-tumor immunity

Cell(2021)10.1016/j.cell.2021.05.038

N/A

0DataRank · unranked

284 citations

Emma De Neef, James D. Thomas, Erich Sabio, Benoı̂t Rousseau, Mathieu Gigoux +30 more

Cancer Selective Target Degradation by Folate-Caged PROTACs

Journal of the American Chemical Society(2021)10.1021/jacs.1c00451

N/A

0DataRank · unranked

291 citations

He Chen, Yi Liu, Yudao Shen, Fanye Meng, H. Ümit Kanıskan +3 more

A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models

Science Translational Medicine(2021)10.1126/scitranslmed.abj1578

N/A

0DataRank · unranked

158 citations

Dongxu Li, Jithesh Kottur, Yudao Shen, Huen Suk Kim, Kwang‐Su Park +14 more

Harnessing the E3 Ligase KEAP1 for Targeted Protein Degradation

Journal of the American Chemical Society(2021)10.1021/jacs.1c04841

N/A

0DataRank · unranked

144 citations

Fanye Meng, Kwang‐Su Park, Hyerin Yim, Julia Velez, Prashasti Kumar +11 more

AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway–Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B

Cancer Discovery(2021)10.1158/2159-8290.cd-20-0815

N/A

0DataRank · unranked

66 citations

Xufen Yu, Tiphaine Martin, Ankita Bansal, Kakit Cheung, Abigail Lubin +15 more

Design, Synthesis, and Evaluation of Potent, Selective, and Bioavailable AKT Kinase Degraders

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c01476

N/A

0DataRank · unranked

54 citations

Jia Xu, Ling Xie, Li Wang, Yudao Shen, Kaitlyn M. Cahuzac +5 more

A First-in-Class, Highly Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 6

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.0c02160

N/A

0DataRank · unranked

27 citations

Fengling Li, Magdalena M. Szewczyk, Levon Halabelian, Irene Chau, Mohammad S. Eram +22 more

EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis

Nature Cell Biology(2022)10.1038/s41556-022-00850-x

N/A

0DataRank · unranked

184 citations

Xufen Yu, Weida Gong, Xijuan Liu, Kwang‐Su Park, Anqi Ma +12 more

Targeting Triple-Negative Breast Cancer by a Novel Proteolysis Targeting Chimera Degrader of Enhancer of Zeste Homolog 2

ACS Pharmacology & Translational Science(2022)10.1021/acsptsci.2c00100

N/A

0DataRank · unranked

62 citations

Chris Anderson, Kwang‐Su Park, H. Ümit Kanıskan, Anqi Ma, Yudao Shen +6 more

Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic

Oncogene(2022)10.1038/s41388-022-02340-8

N/A

0DataRank · unranked

56 citations

Xufen Yu, Jithesh Kottur, Weida Gong, Zhao Zhang, Aaron J. Storey +14 more

Novel Allosteric Inhibitor-Derived AKT Proteolysis Targeting Chimeras (PROTACs) Enable Potent and Selective AKT Degradation in KRAS/BRAF Mutant Cells

Journal of Medicinal Chemistry(2022)10.1021/acs.jmedchem.2c01454

N/A

0DataRank · unranked

35 citations

Jia Xu, Kaitlyn M. Cahuzac, Ling Xie, Yudao Shen, Xian Chen +4 more

Discovery of Potent, Selective, and In Vivo Efficacious AKT Kinase Protein Degraders via Structure–Activity Relationship Studies

Journal of Medicinal Chemistry(2022)10.1021/acs.jmedchem.1c02165

N/A

0DataRank · unranked

39 citations

Jia Xu, Yudao Shen, Kaitlyn M. Cahuzac, Kwang‐Su Park, Brandon Dale +4 more

Exploring Degradation of Mutant and Wild-Type Epidermal Growth Factor Receptors Induced by Proteolysis-Targeting Chimeras

Journal of Medicinal Chemistry(2022)10.1021/acs.jmedchem.2c00345

N/A

0DataRank · unranked

33 citations

Meng Cheng, Kaylene Lu, Yudao Shen, Yue Zhong, Jing Liu +3 more

Dissecting and targeting noncanonical functions of EZH2 in multiple myeloma via an EZH2 degrader

Oncogene(2023)10.1038/s41388-023-02618-5

N/A

0DataRank · unranked

26 citations

Jun Wang, Weida Gong, Anqi Ma, Yudao Shen, Chengwei Zhang +6 more

Discovery of a Potent and Selective Protein Arginine Methyltransferase 5 (PRMT5) PROTAC Degrader

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.5c00198

N/A

0DataRank · unranked

9 citations

Huensuk Kim, Chao Qian, Ling Xie, Xian Chen, Yan Xiong +6 more

Discovery of a First-in-Class Protein Arginine Methyltransferase 6 (PRMT6) Covalent Inhibitor

Journal of Medicinal Chemistry(2020)10.1021/acs.jmedchem.0c00406

N/A

0DataRank · unranked

42 citations

Fengling Li, Magdalena M. Szewczyk, Levon Halabelian, Kwang‐Su Park, Irene Chau +11 more

Epigenomic analysis identifies DTP subpopulation using HOPX to develop targeted therapy resistance in lung adenocarcinoma

iScience(2025)10.1016/j.isci.2025.112387

N/A

0DataRank · unranked

3 citations

Reshmee Bhattacharya, Seungyeul Yoo, Feng Jiang, Eric Park, Genesis Lara Granados +8 more